Cargando…

Patients with MPNs and retinal drusen show signs of complement system dysregulation and a high degree of chronic low-grade inflammation

BACKGROUND: The hematopoietic stem cell disorders, myeloproliferative neoplasms (MPNs), are characterised by chronic low-grade inflammation (CLI). Recently, we showed that patients with MPNs have an increased prevalence of drusen and age-related macular degeneration (AMD), and drusen prevalence seem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liisborg, Charlotte, Skov, Vibe, Kjær, Lasse, Hasselbalch, Hans Carl, Sørensen, Torben Lykke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808164/ https://www.ncbi.nlm.nih.gov/pubmed/35128362 http://dx.doi.org/10.1016/j.eclinm.2021.101248

Ejemplares similares

Retinal drusen in patients with chronic myeloproliferative blood cancers are associated with an increased proportion of senescent T cells and signs of an aging immune system
por: Liisborg, Charlotte, et al.
Publicado: (2021)

Lower CXCR3 expression in both patients with neovascular AMD and advanced stages of chronic myeloproliferative blood cancers
por: Liisborg, Charlotte, et al.
Publicado: (2022)

Serum levels of IL-4, IL-13 and IL-33 in patients with age-related macular degeneration and myeloproliferative neoplasms
por: Gotfredsen, Kathrine, et al.
Publicado: (2023)

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
por: Andersen, Morten, et al.
Publicado: (2017)

Mathematical Modeling of MPNs Offers Understanding and Decision Support for Personalized Treatment
por: Ottesen, Johnny T., et al.
Publicado: (2020)

A novel integrated biomarker index for the assessment of hematological responses in MPNs during treatment with hydroxyurea and interferon‐alpha2
por: Dam, Marc J. B., et al.
Publicado: (2022)

Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
por: Liisborg, Charlotte, et al.
Publicado: (2020)

Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
por: Skov, Vibe
Publicado: (2020)

Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer’s disease: evidences and perspectives
por: Hasselbalch, Hans C., et al.
Publicado: (2020)

MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
por: Hasselbalch, Hans Carl, et al.
Publicado: (2015)

Patients with myeloproliferative neoplasms and high levels of systemic inflammation develop age-related macular degeneration
por: Liisborg, Charlotte, et al.
Publicado: (2020)

Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
por: Hasselbalch, Hans C.
Publicado: (2020)

Whole Blood Transcriptional Profiling Reveals Deregulation of Oxidative and Antioxidative Defence Genes in Myelofibrosis and Related Neoplasms. Potential Implications of Downregulation of Nrf2 for Genomic Instability and Disease Progression
por: Hasselbalch, Hans Carl, et al.
Publicado: (2014)

Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms
por: Skov, Vibe, et al.
Publicado: (2022)

HSC Niche Dynamics in Regeneration, Pre-malignancy, and Cancer: Insights From Mathematical Modeling
por: Pedersen, Rasmus Kristoffer, et al.
Publicado: (2022)

Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives
por: Hasselbalch, Hans, et al.
Publicado: (2022)

JAK2V617F mutation is highly prevalent in patients with ischemic stroke: a case-control study
por: Kristiansen, Marie Hvelplund, et al.
Publicado: (2023)

Elevated levels of oxidized nucleosides in individuals with the JAK2V617F mutation from a general population study
por: Sørensen, Anders L., et al.
Publicado: (2021)

Differential Dynamics of CALR Mutant Allele Burden in Myeloproliferative Neoplasms during Interferon Alfa Treatment
por: Kjær, Lasse, et al.
Publicado: (2016)

Biology and therapeutic targeting of molecular mechanisms in MPNs
por: How, Joan, et al.
Publicado: (2023)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain
por: Bedder, Marshall, et al.
Publicado: (2023)

Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications
por: Chen, Weipeng, et al.
Publicado: (2023)

Soft drusen or not?
por: Shields, Carol L, et al.
Publicado: (2018)

Drusen drizzle
por: Venkatakrishnan, Praveena, et al.
Publicado: (2023)

The transcriptome of peripheral blood mononuclear cells in patients with clinical subtypes of late age-related macular degeneration
por: Subhi, Yousif, et al.
Publicado: (2019)

Transcriptional Profiling of Whole Blood Identifies a Unique 5-Gene Signature for Myelofibrosis and Imminent Myelofibrosis Transformation
por: Hasselbalch, Hans Carl, et al.
Publicado: (2014)

Predictive Value of Kozak Gene Polymorphism for Thrombosis in Patients with Philadelphia-Negative MPNs
por: El-Ghonemy, Mohamed Sabry, et al.
Publicado: (2021)

Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesis
por: Harraka, P., et al.
Publicado: (2022)

Increased retinal drusen in IgA glomerulonephritis are further evidence for complement activation in disease pathogenesis
por: Harraka, P., et al.
Publicado: (2022)

Multiplexed optical coherence tomography imaging of optic disc drusen
por: Karlesand, Isabelle, et al.
Publicado: (2020)

A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNs
por: Schnoeder, Tina M., et al.
Publicado: (2021)

Correction Notice: Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
Publicado: (2020)

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms
por: Hasselbalch, Hans Carl, et al.
Publicado: (2023)

Haplotypes in the Complement Factor H (CFH) Gene: Associations with Drusen and Advanced Age-Related Macular Degeneration
por: Francis, Peter J., et al.
Publicado: (2007)

Evaluating the Occurrence of Rare Variants in the Complement Factor H Gene in Patients With Early-Onset Drusen Maculopathy
por: de Breuk, Anita, et al.
Publicado: (2021)

Artificial Intelligence-Based ChatGPT Responses for Patient Questions on Optic Disc Drusen
por: Potapenko, Ivan, et al.
Publicado: (2023)

Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis
por: Mikkelsen, Stine Ulrik, et al.
Publicado: (2018)

Autofluorescence of optic disc drusens
por: Menia, Nitin K, et al.
Publicado: (2019)

A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis
por: Skov, Vibe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kcgsi13hd3n83ajmq85q5cnugu